⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZNTL News
Zentalis Pharmaceuticals, Inc. Common Stock
Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
globenewswire.com
ZNTL
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL
Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates
globenewswire.com
ZNTL
The Zeigler Kalamazoo Marathon Returns April 25-26, 2026, Bringing Family-Friendly Fun For Everyone
prnewswire.com
BGS
ZNTL
PNC
SYK
PAR
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
globenewswire.com
ZNTL
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL
Zenith Capital Corp. Appoints Bryan Ede to Board of Directors Ready to Announce with Confidence?
newsfilecorp.com
ZNTL
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
ZNTL
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference
globenewswire.com
ZNTL